CN107024370A - A kind of kit of flight time mass spectrum system micro-biological samples pre-treatment - Google Patents
A kind of kit of flight time mass spectrum system micro-biological samples pre-treatment Download PDFInfo
- Publication number
- CN107024370A CN107024370A CN201610696197.6A CN201610696197A CN107024370A CN 107024370 A CN107024370 A CN 107024370A CN 201610696197 A CN201610696197 A CN 201610696197A CN 107024370 A CN107024370 A CN 107024370A
- Authority
- CN
- China
- Prior art keywords
- microorganism
- acetonitrile
- mass spectrometry
- methods
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001819 mass spectrum Methods 0.000 title claims abstract description 35
- 238000002203 pretreatment Methods 0.000 title abstract description 15
- 230000002906 microbiologic effect Effects 0.000 title abstract description 6
- 239000012472 biological sample Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 claims abstract description 272
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 99
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 66
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 64
- 238000001514 detection method Methods 0.000 claims abstract description 62
- 241000894006 Bacteria Species 0.000 claims abstract description 41
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 34
- 239000000203 mixture Substances 0.000 claims abstract description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 99
- 244000005700 microbiome Species 0.000 claims description 80
- 241000894007 species Species 0.000 claims description 36
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 30
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 30
- 238000001269 time-of-flight mass spectrometry Methods 0.000 claims description 28
- 101000623895 Bos taurus Mucin-15 Proteins 0.000 claims description 24
- 230000000813 microbial effect Effects 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- AFVLVVWMAFSXCK-UHFFFAOYSA-N α-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(C#N)=CC1=CC=C(O)C=C1 AFVLVVWMAFSXCK-UHFFFAOYSA-N 0.000 claims description 16
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 15
- 235000019253 formic acid Nutrition 0.000 claims description 15
- 241000233866 Fungi Species 0.000 claims description 11
- 229920001184 polypeptide Polymers 0.000 claims description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- 244000153158 Ammi visnaga Species 0.000 claims description 10
- 235000010585 Ammi visnaga Nutrition 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 238000011160 research Methods 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 7
- 238000012360 testing method Methods 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 4
- 238000003908 quality control method Methods 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 238000003912 environmental pollution Methods 0.000 claims description 2
- 230000008676 import Effects 0.000 claims description 2
- 238000005336 cracking Methods 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 62
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 description 56
- 238000000605 extraction Methods 0.000 description 48
- 239000011159 matrix material Substances 0.000 description 38
- 102000002278 Ribosomal Proteins Human genes 0.000 description 31
- 108010000605 Ribosomal Proteins Proteins 0.000 description 31
- 238000011282 treatment Methods 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 19
- 230000001580 bacterial effect Effects 0.000 description 16
- 238000010586 diagram Methods 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 13
- 238000002156 mixing Methods 0.000 description 13
- 239000000758 substrate Substances 0.000 description 13
- 150000002500 ions Chemical group 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 238000007796 conventional method Methods 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- 238000000576 coating method Methods 0.000 description 9
- 230000009089 cytolysis Effects 0.000 description 9
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 9
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 8
- 241000222173 Candida parapsilosis Species 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 241000194019 Streptococcus mutans Species 0.000 description 8
- 229940055022 candida parapsilosis Drugs 0.000 description 8
- 210000002421 cell wall Anatomy 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 244000052616 bacterial pathogen Species 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 6
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- -1 saccharide compounds Chemical class 0.000 description 5
- BRARRAHGNDUELT-UHFFFAOYSA-N 3-hydroxypicolinic acid Chemical compound OC(=O)C1=NC=CC=C1O BRARRAHGNDUELT-UHFFFAOYSA-N 0.000 description 4
- 241000607528 Aeromonas hydrophila Species 0.000 description 4
- 241000222175 Diutina rugosa Species 0.000 description 4
- 241000588697 Enterobacter cloacae Species 0.000 description 4
- 241000194032 Enterococcus faecalis Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 241000588749 Klebsiella oxytoca Species 0.000 description 4
- 241000588747 Klebsiella pneumoniae Species 0.000 description 4
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 4
- 241000235048 Meyerozyma guilliermondii Species 0.000 description 4
- 241000235645 Pichia kudriavzevii Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 241000607715 Serratia marcescens Species 0.000 description 4
- 241000191963 Staphylococcus epidermidis Species 0.000 description 4
- 241000192087 Staphylococcus hominis Species 0.000 description 4
- 241000193985 Streptococcus agalactiae Species 0.000 description 4
- 241000193998 Streptococcus pneumoniae Species 0.000 description 4
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 4
- 241000509561 [Candida] pseudolambica Species 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 244000000010 microbial pathogen Species 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- GRBBNZYMXKTQAI-UHFFFAOYSA-N 4-methyl-5-nitropyridin-2-amine Chemical compound CC1=CC(N)=NC=C1[N+]([O-])=O GRBBNZYMXKTQAI-UHFFFAOYSA-N 0.000 description 3
- NZNMSOFKMUBTKW-UHFFFAOYSA-N Cyclohexanecarboxylic acid Natural products OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 241000237509 Patinopecten sp. Species 0.000 description 3
- AFVLVVWMAFSXCK-VMPITWQZSA-N alpha-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(\C#N)=C\C1=CC=C(O)C=C1 AFVLVVWMAFSXCK-VMPITWQZSA-N 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000020637 scallop Nutrition 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- AKEUNCKRJATALU-UHFFFAOYSA-N 2,6-dihydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=CC=C1O AKEUNCKRJATALU-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 241000321538 Candidia Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 101100383222 Escherichia coli cba gene Proteins 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 102000006947 Histones Human genes 0.000 description 2
- 108010033040 Histones Proteins 0.000 description 2
- 241000588748 Klebsiella Species 0.000 description 2
- 241000186869 Lactobacillus salivarius Species 0.000 description 2
- 101710116435 Outer membrane protein Proteins 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 108010013381 Porins Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- GNGACRATGGDKBX-UHFFFAOYSA-N dihydroxyacetone phosphate Chemical compound OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 description 2
- 229940032049 enterococcus faecalis Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 229940081066 picolinic acid Drugs 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 102000007739 porin activity proteins Human genes 0.000 description 2
- 238000000751 protein extraction Methods 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PLVPPLCLBIEYEA-AATRIKPKSA-N (E)-3-(indol-3-yl)acrylic acid Chemical compound C1=CC=C2C(/C=C/C(=O)O)=CNC2=C1 PLVPPLCLBIEYEA-AATRIKPKSA-N 0.000 description 1
- IVHXFSFLCMNTQP-UHFFFAOYSA-N 1,3-benzothiazole-4-thiol Chemical compound SC1=CC=CC2=C1N=CS2 IVHXFSFLCMNTQP-UHFFFAOYSA-N 0.000 description 1
- ZUHRGSQCGNLZFH-UHFFFAOYSA-N 1,3-benzothiazole-5-thiol Chemical compound SC1=CC=C2SC=NC2=C1 ZUHRGSQCGNLZFH-UHFFFAOYSA-N 0.000 description 1
- DODWVZSLOOEOKB-UHFFFAOYSA-N 1-benzothiophene-2-thiol Chemical compound C1=CC=C2SC(S)=CC2=C1 DODWVZSLOOEOKB-UHFFFAOYSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- NKYDKCVZNMNZCM-UHFFFAOYSA-N 5-chloro-3h-1,3-benzothiazole-2-thione Chemical compound ClC1=CC=C2SC(S)=NC2=C1 NKYDKCVZNMNZCM-UHFFFAOYSA-N 0.000 description 1
- UGSBCCAHDVCHGI-UHFFFAOYSA-N 5-nitropyridin-2-amine Chemical compound NC1=CC=C([N+]([O-])=O)C=N1 UGSBCCAHDVCHGI-UHFFFAOYSA-N 0.000 description 1
- XJGFWWJLMVZSIG-UHFFFAOYSA-N 9-aminoacridine Chemical compound C1=CC=C2C(N)=C(C=CC=C3)C3=NC2=C1 XJGFWWJLMVZSIG-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- RBZCTPRDBOQKFH-UHFFFAOYSA-N C=CC1=CC=CC=C1.C=CC=C.ClC(Cl)Cl Chemical compound C=CC1=CC=CC=C1.C=CC=C.ClC(Cl)Cl RBZCTPRDBOQKFH-UHFFFAOYSA-N 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- YAHZABJORDUQGO-NQXXGFSBSA-N D-ribulose 1,5-bisphosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)C(=O)COP(O)(O)=O YAHZABJORDUQGO-NQXXGFSBSA-N 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241001481789 Rupicapra Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960001441 aminoacridine Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 239000007621 bhi medium Substances 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000009640 blood culture Methods 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- XCSQXCKDEVRTHN-UHFFFAOYSA-N cyclohexa-1,4-diene-1-carboxylic acid Chemical compound OC(=O)C1=CCC=CC1 XCSQXCKDEVRTHN-UHFFFAOYSA-N 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000003074 dental pulp Anatomy 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 210000002500 microbody Anatomy 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- KLAKIAVEMQMVBT-UHFFFAOYSA-N p-hydroxy-phenacyl alcohol Natural products OCC(=O)C1=CC=C(O)C=C1 KLAKIAVEMQMVBT-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000001322 periplasm Anatomy 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000012175 pyrosequencing Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000001974 tryptic soy broth Substances 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
- G01N27/64—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode using wave or particle radiation to ionise a gas, e.g. in an ionisation chamber
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of reagent composition for flight time mass spectrum system micro-biological samples pre-treatment, said composition can effectively crack bacterium, and the progress Mass Spectrometer Method using total protein as target body.The reagent composition can obtain the characteristic peak spectrogram that signal is strong, discrimination is high, and have the more reliable and stable degree of accuracy for final identification fraction.The present invention also includes the mass spectrometry kit of reagent composition, and detects the preprocess method and detection method of micro-biological samples.
Description
Technical Field
The invention belongs to the technical field of biology, and relates to a kit and a detection product for pretreating a microorganism sample by a time-of-flight mass spectrometry system.
Background
Time of Flight Mass Spectrometer (TOF), a very common Mass Spectrometer whose Mass analyzer is an ion drift tube (ion drift tube) where ions generated by an ion source are first collected, all the ions in the collector become 0, accelerated using a pulsed electric field into a field-free drift tube and fly at a constant velocity towards an ion receiver, the larger the Mass of the ions, the longer it takes to reach the receiver; the smaller the mass of the ions, the shorter the time it takes to reach the receiver, and according to this principle, ions of different masses can be separated in the size of m/z. The flight time mass spectrometer has the advantages of large detectable molecular weight range, high scanning speed and simple instrument structure.
The accuracy rate of the time-of-flight mass spectrometry for completing the detection of the microbial sample can reach 99.9%, and the method has the advantages of high accuracy, strong flexibility, large flux, short detection period and the like, and is most attractive and should also have the cost performance. The time-of-flight mass spectrometry platform (MALDI-TOF) is an international universal research platform for gene Single Nucleotide Polymorphism (SNP), and the method has become a gold standard in the field by virtue of the scientificity and accuracy of the method.
Microorganisms are various in types and complex in composition, and identification results thereof vary depending on growth sites, growth conditions and detection means: according to the growth characteristics of microorganisms, different modes and conditions need to be cultured, and the primary identification is carried out according to the colony morphology and the gram stain; the variation of the microorganism can cause the continuous change of biochemical reaction, and the bacteria with atypical biochemical reaction are difficult to identify; the nucleic acid detection method as the gold standard has accurate and reliable result, but has high technical requirement, time consumption and special operators, and the method has complicated steps and long detection period and cannot timely and effectively guide the application and treatment of antibiotics. Extensive clinical empirical medication leads to an increase in drug-resistant strains, further increasing the difficulty of clinical treatment. Rapid identification of clinical microorganisms has become an urgent problem to be solved. With the development of scientific technology, the processes of dyeing, inoculation culture, biochemistry, serology, drug sensitivity experiment and the like in the microorganism identification are automated to different degrees, and the identification efficiency is greatly improved. In addition, based on the development of molecular biology technology, many methods for rapidly identifying pathogenic microorganisms appear, such as real-time quantitative polymerase chain reaction, restriction fragment length polymorphism analysis, single-strand conformation polymorphism analysis, pyrosequencing technology, fluorescence in situ hybridization, gene chip, etc., for example, Lixiaxia et al (reference 1: medical review, volume 17, phase 13, 7 months 2011) report that the advantages and disadvantages of various detection technologies in clinical application are introduced in the application and research progress of clinical pathogenic bacteria rapid identification technology, and the methods do not need to carry out complex operations of culture separation and biochemical identification on clinical microorganisms, have the characteristics of strong specificity, high sensitivity, good repeatability, high throughput, diversity, miniaturization, automation, etc., and have high requirements on fragment specificity, length limitation and technology required for detecting different bacteria, the spread in clinical microbiological routine is limited.
The method for identifying the microorganisms by using the mass spectrometry technology has the obvious advantages that: (1) the sample is processed simply in the early stage; (2) the operation is simple and rapid, and the flux is high; (3) the sensitivity is high; (4) the accuracy is good. The sample can be directly loaded through a simple protein extraction step, a map is obtained through matrix-assisted laser desorption ionization flight time, and then the obtained map is compared with species/genus specific maps of different microorganism families in a database, so that an identification result can be obtained, and the method is efficient, rapid, low in price and good in clinical application potential. However, Li Xiaoxia et al (2011) also indicate that although TOF MS mass spectrometry can accurately identify pathogenic bacteria and provide key treatment information for infectious diseases, false negative conditions exist, the result may be related to that the content of bacteria in blood culture solution is too low to form a specific recognizable peak, and protein components in blood interfere with the formation of mass spectrometry to a certain extent, so that the accuracy of the identification result is influenced.
Furthermore, in TOF MS techniques, the choice of matrix directly affects the analytical results of the sample. To date, the choice of effective matrix has not been fully theorized and has been obtained only by experimental screening of a large number of compounds. In general, the substrates used in TOFMS are organic acidic compounds, such as cinnamic acid derivatives HCCA and SA, aromatic carboxylic acid derivative 2, 5-dihydroxybenzoic acid (DHB), which are highly efficient substrates for analyzing polypeptides and proteins, and 3-hydroxypicolinic acid (3-HPA) and Picolinic Acid (PA), which are commonly used substrates for DNA analysis, such as XuXinRong et al (reference 2: "Proc. Natl. Acad. Sci. 27, vol. 3, 2011) which report the molecular mass distribution of hydrolyzed collagen protein powder in positive ion mode using α -cyano-4-hydroxycinnamic acid, 2, 5-dihydroxybenzoic acid and sinapic acid, respectively, as substrates. The analysis results show that: sinapic acid is the most suitable substrate, and the analysis condition is the combination of a linear mode and a reflection mode, so that the molecular weight distribution of the hydrolyzed collagen powder can be accurately and quickly determined. The method is superior to other conventional molecular weight determination methods.
As another example of the substrate for analyzing saccharides, 2, 5-dihydroxybenzoic acid (2, 5-DHB), Sinapinic Acid (SA), T-CN-4-hydroxycinnamic Acid (ACHC) and the like are available, for example, Helmink et al (reference 3: Proc. Natl. Acad. Hippocampus, 1998, 7 months) have found a substrate 2,5-DHB suitable for saccharide analysis by comparing the analytical effects of 3 commonly used substrates MALDI-MS of saccharide compounds and the MALDI-MS spectra of oligosaccharide and polysaccharide positive and negative ions, and have studied the process of forming ions under the conditions of laser desorption/ionization of saccharide compounds, and pointed out the important role of N a + and K + ions in the measurement of oligosaccharide molecules, and the molecular weight of glucan having a molecular weight of more than 10000 has been successfully determined by means of column chromatography separation. However, it is not necessary that the compound be acidic and be effective as a substrate, and certain basic compounds may also be useful as substrates. For example, basic substrates reported by Zhou Li Hua et al (reference 4: Proc. Natl. Acad. Sci. higher school Chemicals, 2004, 12.P.) for analyzing polypeptides, proteins and DNAs include 2-amino-4-methyl-5-nitropyridine, 2-amino-5-nitropyridine, p-nitroaniline, 9-aminoacridine and the like. The use of a basic matrix can further expand the scope of application of TOF MS, particularly for the determination of acid sensitive substances.
At present, in TOF MS techniques for detecting microorganisms, the following substrates are commonly used: alpha-cyano-4-hydroxycinnamic acid (CHCA), 2, 5-dihydroxybenzoic acid (2, 5-dihydrobenzoic acid, DHB), 2-amino-4-methyl-5-nitropyridine (2-amino-4-methyl-5-nitropyridine, 2a4m5n), trans-3-indoleacrylic acid (IAA), 2-mercaptobenzothiophene (2-mercaptobenzothiazole, MBT), 2- (4-hydroxyimine) benzoic acid [2- (4-hydroxyheterocyclic) benzoic acid, HABA ], 2, 6-dihydroxybenzoic acid (2, 6-dihydroacetophenone, DHAP), sinapic acid (3, 5-dihydronaphthalene-4-dihydrothiophene, 5-mercaptobenzothiazole), 2-mercaptobenzothiazole (2 a 4-mercaptobenzothiazole, CMBT), for example, bright-day mushroom and the like (reference 5: "sanitation research" volume 37, phase 6, 2008) used a CHCA matrix for the detection and typing of 88 salmonella strains isolated from the stools of outpatient diarrhea patients using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS); lifengqin and the like (reference 6: Chinese food sanitation journal, volume 19, No. 5, 2007) screen matrix, matrix-sample ratio, sample loading method and the like used by MALDI-TOF-MS for detecting food fungi, obtain optimized experimental conditions, and research the reproducibility and practical application of the method. The results show that the MALDI-TOF-MS analysis has different optimal matrixes required by different fungi, and the optimal matrixes of monascus and fusarium are MBT; the most suitable substrates for Aspergillus, Penicillium and yeast are IAA; the optimal base/sample ratio for loading was 1: 1; the mixed liquid drop drying method is the best loading method. While the solvent used to formulate the above matrix is typically acetonitrile, trifluoroacetic acid (TFA) (bright-coloured chamois, lienfenqin), for example acetonitrile +0.1% aqueous TFA (70 + 30, volume fraction), or acetonitrile: TFA: water = 50: 2.5: 47.5 or 50: 0.1: 49.9.
in addition, for the most common microorganism pretreatment Kit VITEK Kit (MS-CHCAMATRIX for use with VITEK MS) commercially available on the market, the VITEK MS-CHCA matrix (yellow cap) reagent main components (required by both bacteria and fungi) are as follows: alpha-cyano-4-hydroxycinnamic acid, VITEK MS-FA (Red cover) reagent main component: 70% formic acid, when treated with this agent against fungi, and then using a matrix of VITEK MS-CHCA. The test kit has the defects that before a time-of-flight mass spectrometry system is used for identifying strains, when fungi or bacteria are uncertain, whether a VITEK MS-CHCA matrix is directly used or a combination of VITEK MS-FA and the VITEK MS-CHCA matrix is used cannot be determined.
For another example, a researcher who purchases a conventional microorganism identification mass spectrometer, such as Autoflex speed TOF/TOF (TOF mass spectrometer) or microflex LT, has two microorganism pretreatment methods, one is a method of directly coating a target plate, bacteria are directly coated on the target plate, and then a user-prepared microorganism sample pretreatment reagent is covered, wherein the reagent comprises the following main components and concentrations: 10mg/ml CHCA base, 50% acetonitrile, 47.5% water and 2.5% trifluoroacetic acid. However, this method is not sufficient for some fungal treatments, and does not effectively lyse the fungal cell wall, and is therefore not suitable for some pathogenic fungi. Another acetonitrile extraction method of formic acid is used for treating strains, and has the disadvantages of multiple steps (3 times of centrifugation), and long time consumption (about 30 min). For this purpose, the acetonitrile formate extraction method used in evaluation of the ability of matrix-assisted laser desorption ionization time-of-flight mass spectrometry to identify clinical bacteria was evaluated by using a high-crystal or the like (reference 10: electronic journal of clinical laboratory management, volume 3, phase 1, 2015): placing a single colony in a 1.5ml Eppendorf tube, adding 300 mul of deionized water and 900 mul of absolute ethyl alcohol, fully and uniformly mixing, centrifuging at 13000 r/min for 2min, and removing supernatant; centrifuging at 13000 r/min for 2min, and sucking and discarding the residual liquid; adding 50 μ l of 70% formic acid, shaking, adding equal amount of acetonitrile, shaking, centrifuging at 13000 r/min for 2min, adding 1 μ l of supernatant dropwise onto MALDI target plate, drying at room temperature, coating 1 μ l of matrix solution on the sample spot, and drying at room temperature; and (6) performing detection on the machine. The system has a detection rate slightly lower than that of a traditional instrument for common bacteria, is more complete in bacteria species identification library, and can be beneficial to detecting special and rare bacteria. Although the method selects more than or equal to 1.7000 points as the judgment score of the strain to be detected, the method has many steps, and partial results still fall into the end points of slightly less than 1.7000 points, 2.000 points and the like, and the results are difficult to be confirmed or need to be verified repeatedly, so that artificial uncontrollable factors are added, the experimental results are different due to the experience of testers, and the judgment score is not completely stable.
The result of TOF mass spectrometry for detecting microorganisms cannot reach 100% accuracy or the identification score has certain variation, which is brought by the principle of mass spectrometry for detecting proteins. Wherein,
protein distribution in bacteria in prokaryotic microorganisms:
(1) the cell wall contains a small amount of outer membrane protein, porin, lipoprotein and the like, and the periplasmic space contains hydrolytic enzymes such as protease, nuclease and the like; synthetases, such as peptidoglycan synthase; a binding protein; a receptor protein.
(2) The cell membrane contains 50% -70% of proteins, and the proteins are mainly transport integrin and enzymatic peripheral proteins.
(3) A cytoplasmic carboxylase comprising ribulose-1, 5-bisphosphate carboxylase; the ribosome contains 34 large subunit proteins and 21 small subunit proteins.
Fungal protein distribution in eukaryotic microorganisms:
(1) the cell wall contains a small amount of protein, structural protein embedded between glucan and mannose; enzymes having catalytic action, such as dextranase, mannanase, sucrase, alkaline phospholipase and esterase, etc.
(2) The protein content of the cytoplasmic membrane is very low, and the sterol is generally contained
(3) The nuclear envelope of the nucleus contains a fibrous layer protein; the chromatin contains histones; non-histones of enzymes involved in transcription by DNA replication.
(4) The cell matrix contains rich proteins such as enzyme and the like, and accounts for 25-50% of the total cell protein; the cytoskeleton consists of a plurality of proteins such as keratin and the like, and has the functions of supporting and moving.
(5) Ribosomes are composed of about 40% protein and 60% RNA, and contain 49 large subunit proteins and 33 small subunit proteins.
(6) Lysosomes contain more than 40 types of acid hydrolases, which are also proteins.
(7) One type of microbody, called the peroxisome, is an organelle containing one or several oxidases, surrounded by a single membrane.
(8) The inner mitochondrial membrane contains ATP synthase complex and 4 kinds of lipoprotein complexes.
(9) Other organelles such as chloroplasts, vacuoles, chitinase, hydrogenase, etc. contain some proteins.
Since the flight mass spectrometry of microorganisms is used to identify species, the size range generally used is just in the range of the high effect of ribosomal protein ionization, which can provide an accurate map with little influence from the growth conditions of microorganisms (reference 7: "test medicine and clinic", volume 9, stage 14, bang, 2012). Therefore, in the current practice OF successfully detecting bacteria and fungi by using time-OF-flight mass spectrometry, the stable expression OF ribosomal proteins in bacteria is detected, Abdessalamc. et al (JOURNAL OF CLINICAL MICROBIOGY, Apr. 2010, p. 1169-, in the research progress of matrix-assisted laser desorption ionization time-of-flight mass spectrometry technology in rapid detection of pathogenic bacteria, the preparation method of the sample has obvious influence on the mass spectrum information of the sample, and in most cases, the pure bacterial colony grown by the culture medium can be directly identified, but the growth time of the bacterial colony is not more than 48 hours, otherwise, the ribosomal protein in the bacterial body is degraded, so that a characteristic peak with strong signal can not be obtained, and the false identification is generated. Certain pathogenic bacteria with tough cell walls, such as fungi, require protein extraction techniques to obtain sufficient quantities of ribosomal proteins to help increase the accuracy of identification. Among them, two commercially available pretreatment products for mass spectrometric detection, used in Abdessalam c. and king, are for the effective extraction of ribosomal proteins in bacteria, and on the analytical software associated with a commercially available mass spectrometer, the bacterial genus judgment standard I: 2.300-3.000 is divided into a complete and reliable identification to the seed level; judgment criterion II: 2.000 to 2.299 are classified into reliable identification to the genus level and possible identification to the species level; judgment standard III: 1.700-1.999 is divided into the possible identification of the genus level; a judgment standard IV: 0.000 to 1.699 were scored as non-confident (reference 10; reference 11: Giovanna Pultrano, Journal of Microbiological Methods 94 (2013) 262-. Therefore, whether the identified microorganisms can obtain stable and accurate identification scores for the time-of-flight mass spectrometry detection technology is crucial to the high-throughput and rapid identification of microorganisms clinically.
However, in order to ensure the accuracy of the identification score of microbial protein by flight time mass spectrometry, the existing research focuses on how to improve the separation and extraction of microbial ribosomal protein, and reports that the colony growth time used in the separation and extraction of microbial ribosomal protein is not more than 48 hours, otherwise, degradation of ribosomal protein is caused, and the identification accuracy is affected. Therefore, the existing related improvement ideas are how to rapidly and efficiently extract ribosomal proteins of bacteria to be detected and avoid the degradation of the ribosomal proteins, so that the ribosomal proteins are accurately used for time-of-flight mass spectrometry (invip, 2013). However, the inventors found that the identification scores of the mass spectrometric detection technique targeting ribosomal proteins and the improved technique thereof sometimes fluctuate among the above 4 criteria, and especially when the theoretical identification score should fall into the credible interval (criterion III) and the actual identification score falls into the untrustworthy interval (criterion IV), repeated detection is sometimes necessary for stability reasons, which is clearly unacceptable for high-throughput and rapid detection in the face of large-scale epidemic outbreaks.
Therefore, a novel time-of-flight mass spectrometry detection technology which can be used for clinically and rapidly identifying pathogenic microorganisms and is repetitive is needed for the requirements of large sample quantity, simple use method, less time consumption and good effect of clinically identifying pathogenic microorganisms.
Disclosure of Invention
As described above, in the prior art, it has been thought that if total microbial proteins are used as a sample to be subjected to mass spectrometry, wherein part of non-ribosomal proteins account for a part of mass spectrometry scores, the mass spectrometry evaluation scores are increased, and a considerable proportion of false positives occurs, thereby affecting the result determination. However, the inventors have surprisingly found that if a suitable combination of cell wall lysis reagent and mass spectrometry matrix is selected, and the lysis time is selected, mass spectrometry detection of total microbial protein can lead to a positive increase in a considerable part of the identification scores of the fluctuations in the judgment intervals III-IV and increase the unreliable results which originally need secondary identification to the reliable intervals without affecting the result of the judgment standard I, II, thereby avoiding the possibility of false negative.
Therefore, the principle of the invention is as follows: based on the existing commercial products and judgment standards, according to the different protein identification principles, the reagent composition and the kit for mass spectrum detection of the pretreatment of the microorganism sample are provided, wherein the reagent composition has the advantages of less steps, short time consumption and capability of efficiently extracting holoprotein of pathogenic bacteria to replace ribosomal protein, and experimental parameters and reagents are optimized. The kit can obtain a characteristic peak spectrogram with strong signals and high discrimination, and has more stable and reliable accuracy for final identification scores.
Based on the principle, the kit is improved from the existing reagent by the following steps: the component I is selected to be used for efficiently crushing cells and releasing total protein, and the component II is selected to be used for crushing cells and releasing total protein and is simultaneously used as a mass spectrum matrix to carry out pre-mass spectrum pretreatment. In particular, formic acid in component I is mainly used for cell disruption; acetonitrile in the component I and the component II can permeate into cells as an organic solvent, promote the release of polypeptide in the cells and effectively extract total protein.
Therefore, the first object of the present invention is to provide a reagent composition for the pretreatment of a time-of-flight mass spectrometry microorganism sample, which comprises the following main components: a component I: acetonitrile and formic acid; and (2) component II: acetonitrile, trifluoroacetic acid and alpha-cyano-4-hydroxycinnamic acid.
In one embodiment, wherein component I comprises:
50.0% (v/v) acetonitrile, 35.0% (v/v) formic acid, and the balance water.
The component II comprises:
52.5% (v/v) acetonitrile, 2.5% (v/v) trifluoroacetic acid, 15mg/ml (m/v) α -cyano-4-hydroxycinnamic acid, and the balance water.
In one embodiment, the initial concentration of acetonitrile is 99.7% by volume (Alfa. Co. Ltd.), the initial concentration of formic acid is 98% by volume (Sigma. Co. Ltd., NO: 94318-250 ml-F), the initial concentration of trifluoroacetic acid is 99% by volume or more (Sigma. Co. Ltd.), and the initial state of alpha-cyano-4-hydroxycinnamic acid is yellow powder (Sigma. Co. Ltd., NO: 70990-1G-F, prepared to be supersaturated in concentration and have yellow powder precipitated)
The second purpose of the invention is to provide the reagent composition for preparing the detection product for identifying the unknown microorganism.
In one embodiment, the product is a time-of-flight mass spectrometry detection kit for microorganisms comprising:
(1) reagent composition for pretreatment of microorganism sample
(2) Other mass spectrometry reagents;
in one embodiment, the kit may further comprise: negative quality control material, positive quality control material, sample application and target sheet for mass spectrum detection.
The third object of the present invention is a method for detecting microorganisms by the above reagent composition or detection product, which improves the peak pattern quality and improves the accuracy of identifying microorganisms by a time-of-flight mass spectrometry system, comprising the steps of:
(1) the microorganisms to be identified are isolated in a suitable medium to obtain single colonies.
(2) Using a sterile toothpick (or 1. mu.l inoculating loop), a portion of the appropriate single colony was picked up in a centrifuge tube containing 10. mu.l of component I, and cell disruption, protein and polypeptide release, and lysis was carried out for 5 minutes.
(3) Mu.l of the above solution was applied to the wells of the target plate and dried at room temperature.
(4) The microtube for component II was opened, and 1. mu.l of component II was removed and added to the same well site and dried at room temperature.
(5) And (4) placing the target plate into a time-of-flight mass spectrometry system for detection.
In one embodiment, the microorganism detection is the determination of the genus, species, subspecies or subtype of microorganism. In a particular embodiment, the detection of microorganisms is of a non-diagnostic purpose to detect pathogenic bacteria, contaminating bacteria, drug-resistant bacteria, and the like.
In another embodiment, the microorganism in any of the above embodiments is a microorganism in environmental pollution, a microorganism in food quarantine, a microorganism in import and export commodities, a drug-resistant microorganism in pharmaceutical research, or the like.
In one embodiment, the microorganism of any of the above embodiments is a prokaryotic microorganism, a eukaryotic microorganism. In a specific embodiment, the prokaryotic microorganism comprises a bacterium. The eukaryotic microorganism is fungi including yeast, mold, etc.
Technical effects
Trifluoroacetic acid in component II is also used for cell disruption, and can act synergistically with formic acid in component I to substantially disrupt cells and substantially release total proteins including ribosomal proteins.
The matrix alpha-cyano-4-hydroxycinnamic acid in the component II mainly has the functions of forming a cocrystallized film on the surface of a biomolecule, absorbing energy from laser by the matrix after laser irradiation generated by a flight time mass spectrum system, and transferring the energy to the biomolecule, so that the biomolecule is ionized. And (3) detecting and analyzing the ionized biomolecules by a time-of-flight mass spectrometry system.
The whole cell protein (including all proteins in the thallus and proteins of cell wall cell membranes) is extracted after the treatment of the kit, so that the characteristic peak intensity of the strain is effectively improved, and the identification accuracy of a time-of-flight mass spectrometer is improved.
The pretreatment of the sample is simple and convenient, and compared with the method of only treating and releasing ribosomal protein, the method has no obvious disadvantages of time and cost;
from the example results, it can be seen that, compared with the control, due to the control mass spectrometry matrix reagent, in the limited space for accommodating bacteria and short drying time, the matrix only partially breaks the cell wall and releases part of the ribosomal protein, and the cell wall protein (such as outer membrane protein, porin, lipoprotein) and enzyme protein in the cell matrix are not separated and released, so that only part of the ribosomal protein in the matrix is excited by the effective laser, thereby completing the mass spectrometry.
However, since the test microorganism is fully lysed in the presence of component I (10. mu.l of component I in a centrifuge tube for 5 minutes) in the present invention, the total intracellular protein is completely released. Therefore, a part of the sample is sucked in the matrix for detection, and the total protein in the matrix can be completely predicted to be excited by the effective laser, so that the mass spectrum is completed.
Therefore, the total protein is fully extracted by pretreating the microorganism, the detection effect is high in flux, the accuracy is stable, and the stability is unexpected compared with the stability of only detecting the ribosomal protein.
Principles and definitions
In the process of detecting substances by a mass spectrum of a time-of-flight mass spectrometry system, the substances to be detected are excited by laser in a vacuum environment under the assistance of a matrix and pass through a flight tube to a detector, and the time of different substances passing through the flight tube is in negative correlation with the molecular weights of the different substances, namely the higher the molecular weight is, the slower the flight speed is and the later the time of the different substances reaching the detector is. The detector can give a spectrum based on the time to reach it (which can be converted to molecular weight) and the intensity. Different microorganisms have different proteins, the whole proteins of the microorganisms are extracted after the microorganism samples are processed, different protein peak patterns, namely different microorganisms, containing different characteristic fingerprint spectrums are detected on a time-of-flight mass spectrometer, and different types of microorganisms can be distinguished by comparing the time-of-flight mass spectrometry system analysis software with the characteristic spectrogram of known pathogenic microorganism in a database, namely the identification result of the microorganism is given.
The term "matrix": the matrix alpha-cyano-4-hydroxycinnamic acid mainly has the functions of forming a cocrystallized film on the surface of a biomolecule, and after laser irradiation generated by a flight time mass spectrum system, the matrix absorbs energy from the laser and transfers the energy to the biomolecule, so that the biomolecule is ionized. And (3) detecting and analyzing the ionized biomolecules by a time-of-flight mass spectrometry system.
Drawings
FIG. 12B shows the appearance of a peak of Staphylococcus epidermidis treated by two methods (the red color of the upper image is CK-M direct smearing method, and the light green color of the lower image is the method and reagent of the invention)
FIG. 22B shows the difference in the appearance of peaks of Staphylococcus epidermidis treated by the two methods (the red color of the upper panel is CK-M direct smearing method, and the light green color of the lower panel is the method and reagent of the present invention)
FIG. 33B shows the appearance of peaks in Staphylococcus hominis treated by the two methods (the red color of the upper panel is CK-M direct smearing method, and the light green color of the lower panel is the method and reagent of the present invention)
FIG. 43B shows the difference in the appearance of peaks of Staphylococcus hominis treated by the two methods (the red color of the upper panel is CK-M direct smearing method, and the light green color of the lower panel is the method and reagent of the present invention)
FIG. 55B shows the appearance of peaks in enterococcus faecalis treated by two methods (the red color of the upper panel is CK-M direct smearing method, and the light green color of the lower panel is the method and reagent of the present invention)
FIG. 65B shows the difference in the appearance of peaks of enterococcus faecalis treated by the two methods (the red color of the upper panel is CK-M direct smearing method, and the light green color of the lower panel is the method and reagent of the present invention)
FIG. 77B shows the appearance of peaks in Streptococcus pneumoniae treated by two methods (the red color in the upper panel is CK-M direct smearing method, and the light green color in the lower panel is the method and reagent of the invention)
FIG. 87B shows the difference in the peak appearance of Streptococcus pneumoniae treated by the two methods (red in the upper panel is CK-M direct smearing method, while light green in the lower panel is the method and reagent of the invention)
FIG. 98B Peak appearance of Streptococcus agalactiae treated by the two methods (Red in the upper panel is CK-M direct smearing method, while light green in the lower panel is the method and reagent of the present invention)
FIG. 108B shows the difference in the peak appearance of Streptococcus agalactiae treated by the two methods (the red color of the upper panel is CK-M direct smearing method, and the light green color of the lower panel is the method and reagent of the present invention)
FIG. 119B shows the appearance of a peak of E.coli treated by two methods (the red color of the upper panel is CK-M direct smearing method, and the light green color of the lower panel is the method and reagent of the present invention)
FIG. 129B shows the difference in the appearance of peaks of E.coli treated by the two methods (the red color of the upper panel is CK-M direct smearing method, and the light green color of the lower panel is the method and reagent of the present invention)
FIG. 1310B shows the appearance of peaks after treatment of Enterobacter cloacae by two methods (the red color in the upper panel is CK-T acetonitrile extraction method, the light green color in the lower panel is the method and reagent of the invention)
FIG. 1410B shows the difference in the appearance of peaks of Enterobacter cloacae treated by the two methods (the red color in the upper panel is CK-T acetonitrile extraction method, and the light green color in the lower panel is the method and reagent of the present invention)
1511A Klebsiella pneumoniae produced by two methods (CK-T formic acid acetonitrile extraction method for red upper part, and the method and reagent for light green lower part)
FIG. 1611A shows the difference in peak appearance of Klebsiella pneumoniae treated by two methods (the red color in the upper panel is CK-T formic acid acetonitrile extraction method, and the light green color in the lower panel is the method and reagent of the present invention)
FIG. 1713B Peak appearance of Pseudomonas aeruginosa treated by two methods (CK-T formic acid acetonitrile extraction method for red upper panel, the method and reagent of the invention for light green lower panel)
FIG. 1813B the difference of peak appearance of Pseudomonas aeruginosa treated by two methods (the red color of the upper panel is CK-T acetonitrile formate extraction method, the light green color of the lower panel is the method and reagent of the present invention)
FIG. 1914A shows that Serratia marcescens treated by two methods (red in the upper part is CK-T acetonitrile formate extraction method, while light green in the lower part is the method and reagent of the present invention)
FIG. 2014A shows the difference of peak appearance of Serratia marcescens treated by two methods (the red color of the upper graph is CK-T formic acid acetonitrile extraction method, and the light green color of the lower graph is the method and the reagent of the invention)
FIG. 2117A is a graph showing the appearance of peaks of Aeromonas hydrophila treated by two methods (red in the upper panel is CK-T formic acid acetonitrile extraction method, while light green in the lower panel is the method and reagent of the present invention)
FIG. 2217A shows the difference of the appearance of peaks of Aeromonas hydrophila treated by two methods (the red color of the upper panel is CK-T formic acid acetonitrile extraction method, the light green color of the lower panel is the method and reagent of the present invention)
FIG. 2338 shows the peak appearance of Klebsiella oxytoca treated by two methods (CK-T formic acid acetonitrile extraction method for red upper panel, the present invention for light green lower panel)
FIG. 2438 shows the difference in the peak-forming conditions of Klebsiella oxytoca treated by two methods (the red color in the upper panel is CK-T formic acid acetonitrile extraction method, and the light green color in the lower panel is the method and reagent of the present invention)
FIG. 25140 peak appearance of Streptococcus mutans treated by two methods (red color in upper panel is CK-T acetonitrile formate extraction method, while light green color in lower panel is the method and reagent of the invention)
26140 Peak Difference in Streptococcus mutans treated with the two methods (Red in the upper panel is CK-T acetonitrile extraction method, while light Green in the lower panel is the method and reagent of the invention)
FIG. 27159 Streptococcus mutans treated by the two methods showed a peak (red in the upper panel is CK-T acetonitrile formate extraction, while light green in the lower panel is the method and reagent of the invention)
FIG. 28159 differences in the appearance of peaks in Streptococcus mutans treated by the two methods (red in the upper panel is CK-T acetonitrile extracted from formic acid; light green in the lower panel is the method and reagent of the invention)
FIG. 29 SLT Lactobacillus rhamnosus treated with two methods and then the peak appearance (the red color of the upper panel is CK-T formic acid acetonitrile extraction method, the light green color of the lower panel is the method and reagent of the invention)
FIG. 30 shows the difference in the appearance of peaks of SLT Lactobacillus rhamnosus treated by two methods (the red color of the upper panel is CK-T formic acid acetonitrile extraction method, and the light green color of the lower panel is the method and reagent of the present invention)
FIG. 3130956 shows the appearance of peaks in Vibrio parahaemolyticus treated by two methods (the red color in the upper panel is CK-T acetonitrile formate extraction method, the light green color in the lower panel is the method and reagent of the present invention)
FIG. 3230956 shows the difference in the appearance of peaks of Vibrio parahaemolyticus treated by the two methods (the red color in the upper panel is CK-T acetonitrile formate extraction method, and the light green color in the lower panel is the method and reagent of the present invention)
FIG. 331A Peak appearance of Staphylococcus aureus treated by two methods (Red in the top panel is CK-M direct plating method, while light Green in the bottom panel is the method and reagent of the invention)
FIG. 341A shows the difference in the appearance of peaks in Staphylococcus aureus treated by the two methods (the red color in the upper panel is CK-M direct plating method, and the light green color in the lower panel is the method and reagent of the present invention)
FIG. 35E 35 peak appearance of Candida krusei treated by two methods (red in the upper panel is CK-T formic acid acetonitrile extraction method, while light green in the lower panel is the method and reagent of the present invention)
FIG. 36E 35 shows the difference in the peak-off behavior of Candida krusei after post-treatment with two methods (red in the upper panel is CK-T formic acid acetonitrile extraction method, while light green in the lower panel is the method and reagent of the present invention)
FIG. 37E 39 peak appearance of Candida guilliermondii after treatment with two methods (red in the upper panel is CK-T formic acid acetonitrile extraction method, light green in the lower panel is the method and reagent of the present invention)
FIG. 38E 39 shows the difference in peak formation of Candida guilliermondii when treated by two methods (red in the upper panel is CK-T formic acid acetonitrile extraction method, while light green in the lower panel is the method and reagent of the present invention)
FIG. 39E 53 Peak appearance of Candida rugosa treated by two methods (red in the upper panel is CK-T formic acid acetonitrile extraction method, while light green in the lower panel is the method and reagent of the present invention)
FIG. 40E 53 peak difference of Candida rugosa treated by two methods (red in the upper panel is CK-T formic acid acetonitrile extraction method, while light green in the lower panel is the method and reagent of the present invention)
FIG. 41E 55 peak appearance of Candida parapsilosis treated by two methods (red in the upper panel is CK-T formic acid acetonitrile extraction method, and light green in the lower panel is the method and reagent of the present invention)
FIG. 42E 55 peak difference of Candida parapsilosis treated by two methods (red in the upper panel is CK-T formic acid acetonitrile extraction method, while light green in the lower panel is the method and reagent of the present invention)
FIG. 43E 58 peak appearance of Candida parapsilosis treated by two methods (CK-T acetonitrile extraction method in upper panel, method and reagent of the present invention in lower panel)
FIG. 44E 58 peak difference of Candida parapsilosis treated by two methods (the upper diagram is CK-T acetonitrile extraction method, the lower diagram is the method and reagent of the present invention)
Detailed Description
In order to further understand the technical features of the present invention, the present invention is described in detail with reference to the specific embodiments below. The embodiments are given by way of illustration only and not by way of limitation, and the scope of the invention should be determined by that of the claims which follow and that of insubstantial modifications made by those skilled in the art based on the teachings of the invention.
The first embodiment is as follows: the method of the invention and the method of directly coating the target plate (CK-M for short) in the traditional mass spectrometry are utilized to pretreat bacteria and then carry out mass spectrometry detection
Sampling a microorganism sample:
detailed information of the species, wherein the incubation conditions were all 5% C02 incubator, incubated for 24 h. As in table 1. The strains are all from the department of Hospital laboratory in Beijing coordination, and the generation time is 2015.11.2.
TABLE 1 detailed information of bacterial species (including medium, incubation time, culture conditions) in example one
Strain numbering | Experiment number | Chinese name of strain | Strain latin name | Culture medium | Pretreatment reagent and experimental method |
2B | 2B-CK-M | Staphylococcus epidermidis | Staphylococcus epidermidis | BAP | Direct smearing method of CK |
2B | 2B-Y | Staphylococcus epidermidis | Staphylococcus epidermidis | BAP | Kits and methods of the invention |
3B | 3B-CK-M | Human staphylococcus | Staphylococcus hominis | BAP | Direct smearing method of CK |
3B | 3B-Y | Human staphylococcus | Staphylococcus hominis | BAP | Kits and methods of the invention |
5B | 5B-CK-M | Enterococcus faecalis | Enterococcus faecalis | BAP | Direct smearing method of CK |
5B | 5B-Y | Enterococcus faecalis | Enterococcus faecalis | BAP | Kits and methods of the invention |
7B | 7B-CK-M | Streptococcus pneumoniae | Streptococcus penumoniae | BAP | Direct smearing method of CK |
7B | 7B-Y | Streptococcus pneumoniae | Streptococcus penumoniae | BAP | Kits and methods of the invention |
8B | 8B-CK-M | Streptococcus agalactiae | Streptococcus agalactiae | BAP | Direct smearing method of CK |
8B | 8B-Y | Streptococcus agalactiae | Streptococcus agalactiae | BAP | Kits and methods of the invention |
9B | 9B-CK-M | Escherichia coli | Escherichia coli | CBA/R | Direct smearing method of CK |
9B | 9B-Y | Escherichia coli | Escherichia coli | CBA/R | Kits and methods of the invention |
(II) sample pretreatment and sample application:
the method of directly coating a target plate (CK-M) in the traditional mass spectrometry pretreatment method is adopted on a commercial TOF instrument, and mass spectrometry matrix reagents (50% (v/v) acetonitrile, 2.5% (v/v) trifluoroacetic acid, 10mg/ml (M/v) alpha-cyano-4-hydroxycinnamic acid and the balance of water) of the CK-M are covered, so that the identification of the strain is carried out on the TOF instrument, and one strain is collected. The method comprises the following specific steps:
1) the microorganisms to be identified are isolated in a suitable medium to obtain single colonies.
2) Single colonies were picked with toothpicks and thinly spread on the target plate.
3) The mass spectrometry matrix reagent covered with 1ul CK-M was dried at room temperature.
4) And putting the target plate into a TOF instrument for mass spectrum detection.
5) And (5) putting the detected data into a biotyper of TOF for identification.
By using the pretreatment method (namely the microbial sample treatment reagent of the flight time mass spectrum system of Beijing-Yixinbo-Chuang biotechnology limited), detection is carried out on TOF, and a strain is collected at one point according to the identification and the scoring of a judgment interval I-IV. The method comprises the following specific steps:
1) the microorganisms to be identified are isolated in a suitable medium to obtain single colonies.
2) Using a sterile toothpick (or 1. mu.l inoculating loop), a portion of the appropriate single colony was picked up in a centrifuge tube containing 10. mu.l of component I, and cell disruption, protein and polypeptide release, and lysis was carried out for 5 minutes.
3) Mu.l of the above solution was applied to the wells of the target plate and dried at room temperature.
4) The microtube for component II was opened, and 1. mu.l of component II was removed and added to the same well site and dried at room temperature.
5) And (4) placing the target plate into a time-of-flight mass spectrometry system for detection.
In this example, microbial samples were processed using different reagents and methods, and the target list schematic on a TOF instrument is shown in table 2:
the target plate of the TOF instrument was 16 × 24=384, and in the schematic diagram, the target was spotted after treatment by two methods according to the same species, respectively, and the treatment methods corresponding to the species numbers in the table (see table 1). Because the mass spectrometer detects proteins, peaks appear in places with proteins, and the difference between the types of total proteins (the invention) and ribosomal proteins (the traditional method) can be known by looking up peak diagrams (such as fig. 1-12) after the two methods are processed.
Table 2 schematic diagram of target list on TOF instrument in example one
1 | 2 | 3 | 4 | 5 | 6 | … | 24 | |
A | 2B-CK-M | 2B-Y | 3B-CK-M | 3B-Y | 5B-CK-M | 5B-Y | ||
B | … | … | … | … | … | … | ||
C | ||||||||
D | ||||||||
E | ||||||||
… | ||||||||
P |
(III) carrying out mass spectrum detection on Autoflex speed TOF/TOF and identifying on software biotyper
From the peak appearance (as shown in fig. 1-12), the peak appearance of the bacteria treated by the method and the reagent of the invention is more than that of the bacteria treated by the traditional method of directly coating the target plate, namely the peak of the non-ribosomal protein, so that the score is high (the score is shown in table 3). For example:
FIG. 2 shows that the number of the strain 2B has 4440.518Da and 6547.576Da more peaks than those of the strain produced by the traditional method; the score is improved from the interval (unreliable interval) of the traditional method with the non-identification result of less than 1.7 points IV to the possible genus of 1.8 points III, and the result of the method has identification significance.
FIG. 6 shows that the number of the strain 5B has 6231.249Da, 6677.828Da, 6863.325, 8887.616 and 9535.425Da more than the peak value of the conventional method; the score is increased from 1.99 to III possible genera to 2.134 to II reliable genera and possible species intervals. And a judgment standard interval is increased.
③ FIG. 12 shows that the number of the strain 9B has the peak values of 4188.513Da, 4767.497Da and 5148.902Da which are increased by using the method compared with the traditional method; the score is increased from the possible genus interval of 1.84 points IV to the species interval determined by 2.497 points I, which obviously improves the detection reliability and accuracy.
TABLE 3 identification of bacteria treated by the direct target coating method of the present invention and conventional methods
Example two: the method and the traditional mass spectrometry method are utilized to perform mass spectrometry detection after the extraction method of acetonitrile formate (CK-T for short) in the invention pretreats bacteria
Sampling a microorganism sample:
the detailed information of the species is shown in Table 4, wherein the culture conditions were the same as in example one. The strains are all from the department of Hospital laboratory in Beijing coordination, and the generation time is 2015.11.2.
TABLE 4 detailed information of bacterial species (including medium, incubation time, culture conditions) in example two
Strain numbering | Experiment number | Chinese name of strain | Strain latin name | Culture medium | Pretreatment reagent and experimental method |
10B | 10B-CK-T | Enterobacter cloacae | Enterobacter cloacae | CBA/R | Method for extracting acetonitrile formate of CK |
10B | 10B-Y | Enterobacter cloacae | Enterobacter cloacae | CBA/R | Kits and methods of the invention |
11A | 11A-CK-T | Klebsiella pneumoniae | klebsiella pneumonia | CBA/R | Method for extracting acetonitrile formate of CK |
11A | 11A-Y | Klebsiella pneumoniae | klebsiella pneumonia | CBA/R | Kits and methods of the invention |
13B | 13B-CK-T | Pseudomonas aeruginosa | Pseudomonas aeruginosa | MH | Method for extracting acetonitrile formate of CK |
13B | 13B-Y | Pseudomonas aeruginosa | Pseudomonas aeruginosa | MH | Kits and methods of the invention |
14A | 14A-CK-T | Serratia marcescens | Serratia marcescens | CBA/R | Method for extracting acetonitrile formate of CK |
14A | 14B-Y | Serratia marcescens | Serratia marcescens | CBA/R | Kits and methods of the invention |
17A | 17A-CK-T | Hydrosophilic single package bacterium | Aeromonas hydrophila | CBA/R | Method for extracting acetonitrile formate of CK |
17A | 19A-Y | Hydrosophilic single package bacterium | Aeromonas hydrophila | CBA/R | Kits and methods of the invention |
38 | 38-CK-T | Acid-producing Klebsiella sp | klebsiella oxytoca | CBA/R | Method for extracting acetonitrile formate of CK |
38 | 38-Y | Acid-producing Klebsiella sp | klebsiella oxytoca | CBA/R | Kits and methods of the invention |
(II) sample pretreatment and sample application:
a commercial instrument Autoflex TOF/TOF is used, a formic acid acetonitrile extraction method (CK-T for short) in a traditional mass spectrum method pretreatment method is adopted, mass spectrum matrix reagents of the CK-T (50% (v/v) acetonitrile, 2.5% (v/v) trifluoroacetic acid, 10mg/ml (m/v) alpha-cyano-4-hydroxycinnamic acid and the balance of water) are covered, strain identification is carried out on the TOF instrument, and one strain is collected. The method comprises the following specific steps:
1) placing a single colony in a 1.5ml Eppendorf tube, adding 300 mul of deionized water and 900 mul of absolute ethyl alcohol, fully and uniformly mixing, centrifuging at 13000 r/min for 2min, and removing supernatant;
2) centrifuging at 13000 r/min for 2min, and sucking and discarding the residual liquid;
3) adding 50 μ l of 70% formic acid, shaking, mixing, adding acetonitrile with equal amount, shaking, mixing, and centrifuging at 13000 r/min for 2 min;
4) dripping 1 μ l of the supernatant on a MALDI target plate, and drying at room temperature;
5) 1 mul of the matrix solution was applied to the sample spot and dried at room temperature;
6) and (6) performing detection on the machine.
By using the pretreatment method (namely the microbial sample treatment reagent of the flight time mass spectrum system of Beijing-Yixinbo-Chuang biotechnology limited), detection, identification and scoring are carried out on Autoflex speed TOF/TOF, and one strain is collected at one point. The method comprises the following specific steps:
1) the microorganisms to be identified are isolated in a suitable medium to obtain single colonies.
2) Using a sterile toothpick (or 1. mu.l inoculating loop), a portion of the appropriate single colony was picked up in a centrifuge tube containing 10. mu.l of component I, and cell disruption, protein and polypeptide release, and lysis was carried out for 5 minutes.
3) Mu.l of the above solution was applied to the wells of the target plate and dried at room temperature.
4) The microtube for component II was opened, and 1. mu.l of component II was removed and added to the same well site and dried at room temperature.
5) And (4) placing the target plate into a time-of-flight mass spectrometry system for detection.
In this example, microbial samples were processed using different reagents and methods, and the target list schematic on a TOF instrument is shown in table 5:
the target plate of the TOF instrument was 16 × 24=384, and in the schematic diagram, the target was spotted by two methods according to the same bacterial species, and the treatment methods corresponding to the bacterial species numbers in the table (see table 4). Because the mass spectrometer detects proteins, peaks appear in places with proteins, and the difference between the types of total proteins (the invention) and ribosomal proteins (the traditional method) can be known by looking up peak diagrams (such as fig. 13-24) after the two methods are processed.
Table 5 schematic diagram of target list on bruke's instrument in example two
1 | 2 | 3 | 4 | 5 | 6 | … | 24 | |
A | 10B-CK-T | 10B-Y | 11A-CK-T | 11A-Y | 13B-CK-T | 13B-Y | ||
B | … | … | … | … | … | … | ||
C | ||||||||
D | ||||||||
E | ||||||||
… | ||||||||
P |
(III) performing mass spectrum detection on TOF instrument and identifying on software biotyper
From the peak appearance (as shown in fig. 13-24), the peak appearance of the bacteria treated by the method and the reagent of the invention is more than that of the traditional acetonitrile formic acid extraction method, namely the peak of the non-ribosomal protein, so that the score is high (the score is shown in table 6). For example:
FIG. 14 shows that the strain number 10B has 2860.400Da, 3051.481Da, 3150.515Da, 3714.672Da, 3857.321Da, 4159.197Da, 4744.479Da, 4923.594Da more than the conventional method; the scoring is improved from the reliable genus possible species interval of 2.123 points II of the traditional method to the reliable species interval of 2.497 points I. And a judgment standard interval is increased.
FIG. 16 shows that the number of the strain with 11A has 8884.181Da and 9147.496Da peak values when the method is used compared with the traditional method; the score is increased from 1.989 to III possible genus interval to 2.225 to II reliable genus, possible species interval. And a judgment standard interval is increased.
③ FIG. 22 shows that the number of the strain with the number of 17A is 4713.251Da which is more than the peak value produced by the traditional method; the scoring is improved from 1.744 points IV possible genus interval to 2.032 points II determined species interval, which obviously improves the detection reliability and accuracy.
TABLE 6 identification of bacteria treated by acetonitrile formate extraction in the present invention and conventional methods
Example three: the method and the extraction method of acetonitrile formate (CK-T for short) in the traditional mass spectrometry method are utilized to treat oral pathogenic bacteria for mass spectrometry detection
Sampling of microorganism samples
3 specimens were taken from the North-university stomatology Hospital (the stored specimens were from patients in whom dental caries was diagnosed in the dental pulp department). The cells were inoculated into BHI medium for streaking. See table 7 for details, wherein the incubation conditions are all 5% C02 incubator for 18 h.
TABLE 7 oral pathogen sampling information
Strain numbering | Experiment number | Bacterial species name | Latin name of strain | Pretreatment reagent and experimental method |
159 | 159-M-T | Streptococcus mutans | streptococcus mutans | Method for extracting acetonitrile formate of CK |
159 | 159-Y | Streptococcus mutans | streptococcus mutans | Kits and methods of the invention |
140 | 140-M-T | Streptococcus mutans | streptococcus mutans | Method for extracting acetonitrile formate of CK |
140 | 140-Y | Streptococcus mutans | streptococcus mutans | Kits and methods of the invention |
741 | 741-M-T | Lactobacillus salivarius | lactobacillus salivarius | Method for extracting acetonitrile formate of CK |
741 | 741-Y | Lactobacillus salivarius | lactobacillus salivarius | Kits and methods of the invention |
SLT | SLT-M-T | Lactobacillus rhamnosus | lactobacillus rhamnosus | Carboxylic acid acetonitrile of CKExtraction method |
SLT | SLT-Y | Lactobacillus rhamnosus | lactobacillus rhamnosus | Kits and methods of the invention |
(II) sample pretreatment and sample application:
a commercial instrument Autoflex TOF/TOF is used, a formic acid acetonitrile extraction method (CK-T for short) in a traditional mass spectrum method pretreatment method is adopted, mass spectrum matrix reagents of the CK-T (50% (v/v) acetonitrile, 2.5% (v/v) trifluoroacetic acid, 10mg/ml (m/v) alpha-cyano-4-hydroxycinnamic acid and the balance of water) are covered, strain identification is carried out on the TOF instrument, and one strain is collected. The method comprises the following specific steps:
1) placing a single colony in a 1.5ml Eppendorf tube, adding 300 mul of deionized water and 900 mul of absolute ethyl alcohol, fully and uniformly mixing, centrifuging at 13000 r/min for 2min, and removing supernatant;
2) centrifuging at 13000 r/min for 2min, and sucking and discarding the residual liquid;
3) adding 50 μ l of 70% formic acid, shaking, mixing, adding acetonitrile with equal amount, shaking, mixing, and centrifuging at 13000 r/min for 2 min;
4) dripping 1 μ l of the supernatant on a MALDI target plate, and drying at room temperature;
5) 1 mul of the matrix solution was applied to the sample spot and dried at room temperature;
6) and (6) performing detection on the machine.
By using the pretreatment method (namely the microbial sample treatment reagent of the flight time mass spectrum system of Beijing-Yixinbo-Biotech Co., Ltd.), identification and scoring of bacteria are carried out on a TOF instrument, and one strain is collected at one point. The method comprises the following specific steps:
1) the microorganisms to be identified are isolated in a suitable medium to obtain single colonies.
2) Using a sterile toothpick (or 1. mu.l inoculating loop), a portion of the appropriate single colony was picked up in a centrifuge tube containing 10. mu.l of component I, and cell disruption, protein and polypeptide release, and lysis was carried out for 5 minutes.
3) Mu.l of the above solution was applied to the wells of the target plate and dried at room temperature.
4) The microtube for component II was opened, and 1. mu.l of component II was removed and added to the same well site and dried at room temperature.
5) And (4) placing the target plate into a time-of-flight mass spectrometry system for detection.
In this example, microbial samples were processed using different reagents and methods, and the target list schematic on a TOF instrument is shown in table 8:
the target plate of the TOF instrument was 16 × 24=384, and in the schematic diagram, the target was spotted by two methods according to the same bacterial species, and the treatment methods corresponding to the bacterial species numbers in the table (see table 7). Because the mass spectrometer detects proteins, peaks appear in places with proteins, and the difference between the types of total proteins (the invention) and ribosomal proteins (the traditional method) can be known by looking up peak diagrams (such as fig. 25-fig. 30) after the two methods are processed.
Table 8 schematic diagram of target list on bruke's instrument in example three
1 | 2 | 3 | 4 | 5 | 6 | … | 24 | |
A | 159-CK-T | 159-Y | 140-CK-T | 140-Y | 741-CK-T | 741-Y | ||
B | … | … | … | … | … | … | ||
C | ||||||||
D | ||||||||
E | ||||||||
… | ||||||||
P |
(III) carrying out mass spectrum detection on a commercial instrument Autoflex speed TOF/TOF and identifying on a software biotype
The experimental strain spectrogram is shown in figures 25-30, and from the peak chart, the peak number of the bacteria treated by the method and the reagent is more than that of the bacteria treated by the traditional formic acid acetonitrile extraction method, namely the peak of the non-ribosomal protein, so that the score is high (the score is shown in table 9). For example:
in FIGS. 27 and 28, it can be seen that the strain number 159 has 5020.137Da peak value compared with the conventional method; the scoring is improved from 1.991 scoring of the possible genus interval of III to 2.011 scoring of the reliable genus and possible species interval of II in the traditional method. And a judgment standard interval is increased.
FIG. 29 and FIG. 30 show that the strain with the number SLT has 7209.869Da peak value compared with the conventional method; the scoring is improved from the reliable category of the possible species interval of 2.011 grade II to the reliable category interval of 2.34 grade I, a judgment standard interval is improved, and the reliability and the accuracy are obviously improved.
TABLE 9 details of the identification of oral pathogens
Example four: the method and the extraction method of acetonitrile formate (CK-T for short) in the traditional mass spectrometry method are utilized to carry out mass spectrometry detection on pathogenic bacteria-vibrio parahaemolyticus in food
(I) preparation of a microbiological sample
1) Sampling 25 g of scallop meat and body fluid of scallop to be detected by aseptic technique, adding 225mL of 3% sodium chloride alkali peptone water
Homogenizing with rotary blade type homogenizer at 8000 r/min for 1 min, or beating with beating type homogenizer for 2min to obtain product 1:10
Homogenizing the sample. If no homogenizer is available, putting the sample into a sterile mortar, taking a small amount of diluent from 225mL of 3% sodium chloride alkali peptone water, adding the diluent into the sterile mortar, grinding the sample, putting the ground sample into a 500 mL sterile conical flask, washing the residual sample in the mortar for 1-2 times by using the small amount of diluent, putting the washing liquid into the conical flask, finally putting all the residual diluent into the conical flask, and fully oscillating to prepare a 1:10 sample uniform liquid.
2) And culturing the sample homogeneous solution at 36 +/-1 ℃ for 8-18 h.
3) And (3) dipping a ring of enrichment fluid in a distance of 1cm below the liquid level by using an inoculating ring for all enrichment fluids which show growth, and scribing and separating on a TCBS (trichloromethane-butadiene-styrene) plate or a vibrio chromogenic culture medium plate. Culturing for 18-24 h at 36 +/-1 ℃.
4) A single colony was picked from the plate, numbered 30956.
5) The bacteria numbered 30956 were treated with the formic acid acetonitrile extraction method (abbreviated as CK-T) in the method of the present invention and the conventional mass spectrometry method, respectively. The strain information is shown in Table 10.
Information of strains cultured in shellfish meat and body fluid of Epimen 10 scallop
Strain numbering | Experiment number | Bacterial species name | Latin name of strain | Pretreatment reagent and experimental method |
30956 | 30956-CK-T | Vibrio parahaemolyticus | Vibrio Parahemolyticus | Method for extracting acetonitrile formate of CK |
30956 | 30956-Y | Vibrio parahaemolyticus | Vibrio Parahemolyticus | Kit and method of the inventionMethod of producing a composite material |
(II) sample pretreatment and sample application:
a commercial instrument Autoflex TOF/TOF is used, a formic acid acetonitrile extraction method (CK-T for short) in a traditional mass spectrum method pretreatment method is adopted, mass spectrum matrix reagents of the CK-T (50% (v/v) acetonitrile, 2.5% (v/v) trifluoroacetic acid, 10mg/ml (m/v) alpha-cyano-4-hydroxycinnamic acid and the balance of water) are covered, strain identification is carried out on the TOF instrument, and one strain is collected. The method comprises the following specific steps:
1) placing a single colony in a 1.5ml Eppendorf tube, adding 300 mul of deionized water and 900 mul of absolute ethyl alcohol, fully and uniformly mixing, centrifuging at 13000 r/min for 2min, and removing supernatant;
2) centrifuging at 13000 r/min for 2min, and sucking and discarding the residual liquid;
3) adding 50 μ l of 70% formic acid, shaking, mixing, adding acetonitrile with equal amount, shaking, mixing, and centrifuging at 13000 r/min for 2 min;
4) dripping 1 μ l of the supernatant on a MALDI target plate, and drying at room temperature;
5) 1 mul of the matrix solution was applied to the sample spot and dried at room temperature;
6) and (6) performing detection on the machine.
By using the pretreatment method (namely the microbial sample treatment reagent of the flight time mass spectrum system of Beijing-Yixinbo-Biotech Co., Ltd.), identification and scoring of bacteria are carried out on a TOF instrument, and one strain is collected at one point. The method comprises the following specific steps:
1) the microorganisms to be identified are isolated in a suitable medium to obtain single colonies.
2) Using a sterile toothpick (or 1. mu.l inoculating loop), a portion of the appropriate single colony was picked up in a centrifuge tube containing 10. mu.l of component I, and cell disruption, protein and polypeptide release, and lysis was carried out for 5 minutes.
3) Mu.l of the above solution was applied to the wells of the target plate and dried at room temperature.
4) The microtube for component II was opened, and 1. mu.l of component II was removed and added to the same well site and dried at room temperature.
5) And (4) placing the target plate into a time-of-flight mass spectrometry system for detection.
In this example, microbial samples were processed using different reagents and methods, and the target simple schematic on a TOF instrument is shown in table 11:
the target plate of the TOF instrument was 16 × 24=384, and in the schematic diagram, the target was spotted by two methods according to the same bacterial species, and the treatment methods corresponding to the bacterial species numbers in the table (see table 10). Because the mass spectrometer detects proteins, peaks appear in places with proteins, and the difference between the types of total proteins (the invention) and ribosomal proteins (the traditional method) can be known by checking peak graphs (such as figures 31-32) after the two methods are processed.
TABLE 11 example four TOF Instrument on target sheet schematic
1 | 2 | 3 | 4 | 5 | 6 | … | 24 | |
A | 30956-CK-T | 30956-Y | ||||||
B | ||||||||
C | ||||||||
D | ||||||||
E | ||||||||
… | ||||||||
P |
(III) carrying out mass spectrum detection on a commercial instrument Autoflex speed TOF/TOF and identifying on a software biotype
The experimental strain spectrogram is shown in fig. 31-32, and from the peak chart, the peak number of the bacteria treated by the method and the reagent is more than that of the bacteria treated by the traditional formic acid acetonitrile extraction method, namely the peak of the non-ribosomal protein, so that the score is high (the score is shown in table 12). For example:
in FIGS. 31 and 32, it can be seen that the strain number 30956 has a peak value of 5775.785Da when compared with the conventional method; the score is improved from the traditional method 1.995 score III possible genus interval to 2.007 score II reliable genus, possible species interval. Improves a judgment standard interval, reliability and accuracy
TABLE 12 identification of pathogens in food products treated by two methods
Example five: the method of the invention and the method of directly coating the target plate (CK-M for short) in the traditional mass spectrometry method are utilized to detect the staphylococcus aureus in the drainage ditch of the pigsty
(I) preparation of a microbiological sample
1) 25mL of the drainage ditch liquid was aspirated into 225mL of 7.5% NaCl broth or 10% NaCl trypticase soy broth in a sterile conical flask (a suitable number of sterile glass beads can be placed inside the flask) and shaken to mix.
2) And culturing the sample homogeneous solution at 36 +/-1 ℃ for 18-24 h.
3) And streaking the culture on a Columbia blood plate, and culturing for 18-24 h at 36 +/-1 ℃.
4) A single colony was picked from the plate and numbered 1A.
5) The bacteria numbered 1A are treated by the method of the invention and the method of extracting acetonitrile formate (CK-M for short) in the traditional mass spectrometry respectively. The strain information is shown in Table 13.
TABLE 13 Strain information in drainage ditches of hog houses
Strain numbering | Experiment number | Bacterial species name | Latin name of strain | Pretreatment reagent and experimental method |
1A | 1A-CK-M | Staphylococcus aureus | Staphylococcus aureus | Direct smearing method of CK |
1A | 1A-Y | Staphylococcus aureus | Staphylococcus aureus | Kits and methods of the invention |
(II) sample pretreatment and sample application:
a commercial instrument Autoflex TOF/TOF is used, a method (CK-M) of directly coating a target plate in a traditional mass spectrum method pretreatment method is adopted, mass spectrum matrix reagent {50% (v/v) acetonitrile, 2.5% (v/v) trifluoroacetic acid, 10mg/ml (M/v) alpha-cyano-4-hydroxycinnamic acid and the balance of water } of the CK-M are covered, strain identification is carried out on the TOF instrument, and one strain is collected. The method comprises the following specific steps:
1) the microorganisms to be identified are isolated in a suitable medium to obtain single colonies.
2) Single colonies were picked with toothpicks and thinly spread on the target plate.
3) The mass spectrometry matrix reagent covered with 1ul CK-M was dried at room temperature.
4) The target plate was placed in a bruke instrument for mass spectrometric detection.
5) And putting the detected data into a biotyper of the Bruk for identification.
By using the pretreatment method (namely the microbial sample treatment reagent of the flight time mass spectrum system of Beijing-Yixinbo-Biotech Co., Ltd.), identification and scoring of bacteria are carried out on a TOF instrument, and one strain is collected at one point. The method comprises the following specific steps:
1) the microorganisms to be identified are isolated in a suitable medium to obtain single colonies.
2) Using a sterile toothpick (or 1. mu.l inoculating loop), a portion of the appropriate single colony was picked up in a centrifuge tube containing 10. mu.l of component I, and cell disruption, protein and polypeptide release, and lysis was carried out for 5 minutes.
3) Mu.l of the above solution was applied to the wells of the target plate and dried at room temperature.
4) The microtube for component II was opened, and 1. mu.l of component II was removed and added to the same well site and dried at room temperature.
5) And (4) placing the target plate into a time-of-flight mass spectrometry system for detection.
In this example, microbial samples were processed using different reagents and methods, and the target list schematic on a TOF instrument is shown in table 14:
the target plate of the TOF instrument is a 16 × 24=384 target plate, and in the schematic diagram, the target is spotted after being treated by two methods according to the same strain, and the treatment methods corresponding to the numbers of the strains in the table are shown in table 13. Because the mass spectrometer detects proteins, peaks appear in places with proteins, and the difference between the types of total proteins (the invention) and ribosomal proteins (the traditional method) can be known by looking up peak graphs (fig. 33-34) after the two methods are processed.
TABLE 14 Bruk Instrument Upper target sheet schematic
1 | 2 | 3 | 4 | 5 | 6 | … | 24 | |
A | 1A-CK-M | 1A-Y | ||||||
B | ||||||||
C | ||||||||
D | ||||||||
E | ||||||||
… | ||||||||
P |
(III) carrying out mass spectrum detection on a commercial instrument Autoflex speed TOF/TOF and identifying on a software biotype
The experimental strain spectrogram is shown in fig. 33-34, and from the peak chart, the peak number of the bacteria treated by the method and the reagent is more than that of the bacteria treated by the traditional formic acid acetonitrile extraction method, namely the peak of the non-ribosomal protein, so that the score is high (the score is shown in table 15). For example:
in FIGS. 33 and 34, the number 1A of the strains has additional peak values of 2637.299Da, 2665.975Da, 3322.036Da, 3447.747Da, 3550.657Da, 4081.480Da, 4235.034Da, 4451.015Da and 4819.054Da compared with the conventional method; the score is improved from the traditional method 1.835 score III possible genus interval to 2.226 score II reliable genus, possible species interval. Improves a judgment standard interval, reliability and accuracy
TABLE 15 identification results of pathogens in drainage ditches of piggeries treated by two methods
Example six: the method and the traditional mass spectrometry method are utilized to perform mass spectrometry detection after the extraction method of acetonitrile formate (CK-T for short) in the invention pretreats fungi
Sampling a microorganism sample:
detailed information of the strains, wherein all the culture media are YPD culture media and all the conditions of the incubator are 37 ℃. As in table 16. The strain is from fungus laboratory of institute of microbiology of Chinese academy of sciences, and the generation time is 2015.11.2.
TABLE 16 example details of six fungal species (including medium, incubation time, culture conditions)
Strain numbering | Experiment number | Bacterial species name | Latin name of strain | Pretreatment reagent and experimental method |
E35 | E35-CK-T | Candida Krusei | Candidia krusei | Method for extracting acetonitrile formate of CK |
E35 | E35-Y | Candida Krusei | Candidia krusei | Kits and methods of the invention |
E39 | E39-CK-T | Candida guilliermondii | Candida guilliermondii | Method for extracting acetonitrile formate of CK |
E39 | E39-Y | Candida guilliermondii | Candida guilliermondii | Kits and methods of the invention |
E53 | E53-CK-T | Candida rugosa | Candida rugosa | Method for extracting acetonitrile formate of CK |
E53 | E53-Y | Candida rugosa | Candida rugosa | Kits and methods of the invention |
E55 | E55-CK-T | Candida parapsilosis | Candida pseudolambica | Method for extracting acetonitrile formate of CK |
E55 | E55-Y | Candida parapsilosis | Candida pseudolambica | Kits and methods of the invention |
E58 | E58-CK-T | Candida parapsilosis | Candida pseudolambica | Method for extracting acetonitrile formate of CK |
E58 | E58-Y | Candida parapsilosis | Candida pseudolambica | Kits and methods of the invention |
(II) sample pretreatment and sample application:
a method (CK-M) of directly coating a target plate in a traditional mass spectrum method pretreatment method is adopted on a commercial instrument Autoflex TOF/TOF, then mass spectrum matrix reagent {50% (v/v) acetonitrile, 2.5% (v/v) trifluoroacetic acid, 10mg/ml (M/v) alpha-cyano-4-hydroxycinnamic acid and the balance of water } of the CK-M are covered, strain identification is carried out on the Autoflex TOF/TOF instrument, and one strain is collected. The method comprises the following specific steps:
1) placing a single colony in a 1.5ml Eppendorf tube, adding 300 mul of deionized water and 900 mul of absolute ethyl alcohol, fully and uniformly mixing, centrifuging at 13000 r/min for 2min, and removing supernatant;
2) centrifuging at 13000 r/min for 2min, and sucking and discarding the residual liquid;
3) adding 50 μ l of 70% formic acid, shaking, mixing, adding acetonitrile with equal amount, shaking, mixing, and centrifuging at 13000 r/min for 2 min;
4) dripping 1 μ l of the supernatant on a MALDI target plate, and drying at room temperature;
5) 1 mul of the matrix solution was applied to the sample spot and dried at room temperature;
6) and (6) performing detection on the machine.
The pretreatment method (namely, a microorganism sample treatment reagent of a flight time mass spectrum system of Beijing-Yixinbo-Chuang biotechnology limited) is used for detecting on an Autoflex speed TOF/TOF, and one strain is collected at one point according to the identification and scoring of a judgment interval I-IV. The method comprises the following specific steps:
1) the microorganisms to be identified are isolated in a suitable medium to obtain single colonies.
2) Using a sterile toothpick (or 1. mu.l inoculating loop), a portion of the appropriate single colony was picked up in a centrifuge tube containing 10. mu.l of component I, and cell disruption, protein and polypeptide release, and lysis was carried out for 5 minutes.
3) Mu.l of the above solution was applied to the wells of the target plate and dried at room temperature.
4) The microtube for component II was opened, and 1. mu.l of component II was removed and added to the same well site and dried at room temperature.
5) And (4) placing the target plate into a time-of-flight mass spectrometry system for detection.
In this example, microbial samples were processed using different reagents and methods, and the target simple diagrams on TOF instruments are shown in table 17:
the target plate of the TOF instrument was 16 × 24=384, and in the schematic diagram, the target was spotted by two methods for the same species, and the treatment methods corresponding to the species numbers in the table (see table 16). Because the mass spectrometer detects proteins, peaks appear in places with proteins, and the difference between the types of total proteins (the invention) and ribosomal proteins (the traditional method) can be known by looking up peak graphs (such as figures 35-42) after the two methods are processed.
TABLE 17 schematic diagram of target list on TOF instrument in example one
1 | 2 | 3 | 4 | 5 | 6 | … | 24 | |
A | E35-CK-T | E35-Y | E39-CK-T | E39-Y | E53-CK-T | E53-Y | ||
B | E55-CK-T | E55-Y | E58-CK-T | E58-Y | … | |||
C | ||||||||
D | ||||||||
E | ||||||||
… | ||||||||
P |
(III) carrying out mass spectrum detection on Autoflex speed TOF/TOF and identifying on software biotyper
From the peak appearance (as shown in FIGS. 35-42), the bacteria treated by the method and the reagent of the present invention showed more peaks than the conventional acetonitrile formate method, i.e., the non-ribosomal protein peaks, and thus the score was high (as shown in Table 18). For example:
in FIGS. 35-36, the strain E35 has the peak values of 5906.755Da, 6278.609Da and 6942.736Da when compared with the conventional method; the scoring is improved from the 2.015-II determined possible species interval of the traditional method to the 2.39-I completely credible species interval, and the method results in that the detection reliability and accuracy are obviously improved.
From FIGS. 41 to 42, it can be seen that the strain with the number E58 has the peak values of 4325.176Da and 4637.467Da when compared with the conventional method, and the score is increased from 1.832 to III to 2.084 to II. The invention improves a judgment standard interval and has identification significance.
TABLE 18 identification of bacteria treated by acetonitrile formate extraction in the present invention and conventional methods
Claims (10)
1. A reagent composition for time-of-flight mass spectrometry microbial sample pretreatment, comprising: a component I: acetonitrile and formic acid; and (2) component II: acetonitrile, trifluoroacetic acid and alpha-cyano-4-hydroxycinnamic acid.
2. The pretreatment reagent composition according to claim 1, wherein
The component I comprises: 50.0% (v/v) acetonitrile, 35.0% (v/v) formic acid, and the balance water;
the component II comprises: 52.5% (v/v) acetonitrile, 2.5% (v/v) trifluoroacetic acid, 15mg/ml (m/v) α -cyano-4-hydroxycinnamic acid, and the balance water.
3. A test product prepared from the reagent composition of claim 1 or 2 for identifying an unknown microorganism.
4. The test product of claim 3, wherein the test product is a time-of-flight mass spectrometry detection kit for microorganisms comprising:
(1) reagent composition for pretreatment of microorganism sample
(2) Other mass spectrometry reagents.
5. The test product of claim 4, wherein the kit further comprises: negative quality control material, positive quality control material, sample application and target sheet for mass spectrum detection.
6. The method for detecting the microorganisms by the reagent composition or the detection product improves the peak image quality and improves the accuracy of identifying the microorganisms by a time-of-flight mass spectrometry system, and comprises the following steps:
(1) separating the microorganism to be identified in a suitable culture medium to obtain a single colony;
(2) selecting a part of appropriate single colony by using a sterilized toothpick (or 1 mul inoculating loop) and placing the single colony in a centrifuge tube filled with 10 mul of the component I for cell disruption, releasing protein and polypeptide and cracking for 5 minutes;
(3) adding 1 μ l of the above solution to the hole of the target plate, and drying at room temperature;
(4) opening the microtube of the component II, transferring 1 mul of the component II to the same hole, and drying at room temperature;
(5) and (4) placing the target plate into a time-of-flight mass spectrometry system for detection.
7. The method of claim 6, wherein the microbial detection is determination of the genus, species, subspecies or subtype of microorganism.
8. The method of claim 6 or 7, wherein the microorganism is a microorganism in environmental pollution, a microorganism in food quarantine, a microorganism in import and export commodities, a drug-resistant microorganism in pharmaceutical research, or the like.
9. The method of claim 8, wherein the microorganism is a prokaryotic microorganism, a eukaryotic microorganism.
10. The method of claim 9, wherein the prokaryotic microorganism comprises a bacterium and the eukaryotic microorganism is a fungus comprising a yeast, a mold, and the like.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810334598.6A CN108507845B (en) | 2016-08-20 | 2016-08-20 | Kit for pretreatment of microbial sample of time-of-flight mass spectrometry system |
CN201610696197.6A CN107024370B (en) | 2016-08-20 | 2016-08-20 | A kind of kit of flight time mass spectrum system micro-biological samples pre-treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610696197.6A CN107024370B (en) | 2016-08-20 | 2016-08-20 | A kind of kit of flight time mass spectrum system micro-biological samples pre-treatment |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810334598.6A Division CN108507845B (en) | 2016-08-20 | 2016-08-20 | Kit for pretreatment of microbial sample of time-of-flight mass spectrometry system |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107024370A true CN107024370A (en) | 2017-08-08 |
CN107024370B CN107024370B (en) | 2018-07-27 |
Family
ID=59524671
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610696197.6A Expired - Fee Related CN107024370B (en) | 2016-08-20 | 2016-08-20 | A kind of kit of flight time mass spectrum system micro-biological samples pre-treatment |
CN201810334598.6A Active CN108507845B (en) | 2016-08-20 | 2016-08-20 | Kit for pretreatment of microbial sample of time-of-flight mass spectrometry system |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810334598.6A Active CN108507845B (en) | 2016-08-20 | 2016-08-20 | Kit for pretreatment of microbial sample of time-of-flight mass spectrometry system |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN107024370B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107917950A (en) * | 2017-10-31 | 2018-04-17 | 中国疾病预防控制中心传染病预防控制所 | Tiretube process microorganism mass spectrum detection kit with biological safety |
CN108048296A (en) * | 2017-11-02 | 2018-05-18 | 暨南大学 | The application of the real-time method for separating and detecting of microorganism and separation detecting device in the identification of microorganism separation detection |
CN111876343A (en) * | 2020-06-24 | 2020-11-03 | 四川省农业科学院分析测试中心 | Mass spectrometry method for detecting Klebsiella pneumoniae in instant fresh fruits and vegetables |
CN112005108A (en) * | 2018-04-16 | 2020-11-27 | 株式会社岛津制作所 | Reagent kit for mass spectrometry, reagent kit for microorganism identification, method for preparing sample, method for analysis, and method for identifying microorganism |
CN113466320A (en) * | 2021-08-06 | 2021-10-01 | 河北省食品检验研究院 | MALDI-TOF detection method for bovine-derived components in milk powder |
CN114184668A (en) * | 2020-09-15 | 2022-03-15 | 广州禾信康源医疗科技有限公司 | Microorganism identification method and bipolar standard spectrogram generation method |
CN114323876B (en) * | 2022-03-14 | 2022-05-13 | 广东江门中医药职业学院 | Method for detecting cloxacillin drug residue in aquatic product |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110031576A (en) * | 2019-04-12 | 2019-07-19 | 华南农业大学 | A kind of method that quick detection produces tetracycline antibiotics degrading enzyme bacterium |
CN111678968A (en) * | 2020-05-13 | 2020-09-18 | 重庆中元汇吉生物技术有限公司 | Pretreatment method for detecting mould by mass spectrometry |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102818837A (en) * | 2012-04-17 | 2012-12-12 | 深圳出入境检验检疫局动植物检验检疫技术中心 | Protein fingerprint model, system and application thereof for anthrax |
CN104931572A (en) * | 2015-05-14 | 2015-09-23 | 中国疾病预防控制中心传染病预防控制所 | Mass spectrometer molecular weight calibration standard for microbiological assay, and preparation method and application thereof |
CN105758926A (en) * | 2016-02-03 | 2016-07-13 | 胡成进 | Method for establishing fingerprint map of marine vibrio and fingerprint map of marine vibrio |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101710097B (en) * | 2009-12-02 | 2012-11-07 | 中国科学院长春应用化学研究所 | Method for detecting aconitine in-vitro metabolic product by matrix assisted laser desorption mass spectrum |
US20130236977A1 (en) * | 2010-05-24 | 2013-09-12 | Children's Medical Center Corporation | Compositions and methods for plasma peptide analysis |
CN103454428A (en) * | 2012-06-05 | 2013-12-18 | 许洋 | Novel immunomic mass spectrometry kit for detecting individualized insulin and preparation method thereof |
CN103267822B (en) * | 2013-05-17 | 2015-04-01 | 浙江省疾病预防控制中心 | Bovine lactoferrin quantitative detection kit and application thereof |
-
2016
- 2016-08-20 CN CN201610696197.6A patent/CN107024370B/en not_active Expired - Fee Related
- 2016-08-20 CN CN201810334598.6A patent/CN108507845B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102818837A (en) * | 2012-04-17 | 2012-12-12 | 深圳出入境检验检疫局动植物检验检疫技术中心 | Protein fingerprint model, system and application thereof for anthrax |
CN104931572A (en) * | 2015-05-14 | 2015-09-23 | 中国疾病预防控制中心传染病预防控制所 | Mass spectrometer molecular weight calibration standard for microbiological assay, and preparation method and application thereof |
CN105758926A (en) * | 2016-02-03 | 2016-07-13 | 胡成进 | Method for establishing fingerprint map of marine vibrio and fingerprint map of marine vibrio |
Non-Patent Citations (3)
Title |
---|
Y.T. CHO ET AL.: "Differentiation of virulence of Helicobacter pylori by matrix-assisted laser desorption/ionization mass spectrometry and multivariate analyses", 《CLINICA CHIMICA ACTA》 * |
王晔茹等: "基质辅助激光解吸/电离飞行时间质谱在沙门菌检测和鉴定分型中的应用研究", 《卫生研究》 * |
高晶晶等: "评价基质辅助激光解吸电离飞行时间质谱鉴定临床病原菌的效果", 《中华临床实验室管理电子杂志》 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107917950A (en) * | 2017-10-31 | 2018-04-17 | 中国疾病预防控制中心传染病预防控制所 | Tiretube process microorganism mass spectrum detection kit with biological safety |
CN108048296A (en) * | 2017-11-02 | 2018-05-18 | 暨南大学 | The application of the real-time method for separating and detecting of microorganism and separation detecting device in the identification of microorganism separation detection |
CN108048296B (en) * | 2017-11-02 | 2021-06-11 | 暨南大学 | Microorganism real-time separation detection method and application of separation detection device in microorganism separation detection identification |
CN112005108A (en) * | 2018-04-16 | 2020-11-27 | 株式会社岛津制作所 | Reagent kit for mass spectrometry, reagent kit for microorganism identification, method for preparing sample, method for analysis, and method for identifying microorganism |
CN111876343A (en) * | 2020-06-24 | 2020-11-03 | 四川省农业科学院分析测试中心 | Mass spectrometry method for detecting Klebsiella pneumoniae in instant fresh fruits and vegetables |
CN114184668A (en) * | 2020-09-15 | 2022-03-15 | 广州禾信康源医疗科技有限公司 | Microorganism identification method and bipolar standard spectrogram generation method |
CN114184668B (en) * | 2020-09-15 | 2024-03-26 | 广州禾信康源医疗科技有限公司 | Microorganism identification method and bipolar standard spectrogram generation method |
CN113466320A (en) * | 2021-08-06 | 2021-10-01 | 河北省食品检验研究院 | MALDI-TOF detection method for bovine-derived components in milk powder |
CN113466320B (en) * | 2021-08-06 | 2022-10-14 | 河北省食品检验研究院 | MALDI-TOF detection method for bovine-derived components in milk powder |
CN114323876B (en) * | 2022-03-14 | 2022-05-13 | 广东江门中医药职业学院 | Method for detecting cloxacillin drug residue in aquatic product |
Also Published As
Publication number | Publication date |
---|---|
CN108507845B (en) | 2021-03-23 |
CN107024370B (en) | 2018-07-27 |
CN108507845A (en) | 2018-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108507845B (en) | Kit for pretreatment of microbial sample of time-of-flight mass spectrometry system | |
Van Belkum et al. | Matrix-assisted laser desorption ionization time-of-flight mass spectrometry in clinical microbiology: what are the current issues? | |
Santos et al. | Filamentous fungal characterizations by matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry | |
Bader | Fungal species identification by MALDI-ToF mass spectrometry | |
Azrad et al. | Cheap and rapid in-house method for direct identification of positive blood cultures by MALDI-TOF MS technology | |
Moura et al. | MALDI-TOF mass spectrometry as a tool for differentiation of invasive and noninvasive Streptococcus pyogenes isolates | |
EP2403957B1 (en) | Method for identifying germs in a liquid medium | |
CN111254185B (en) | Mass spectrometry resistance determination by growth measurement | |
Luethy et al. | Rapid one-step extraction method for the identification of molds using MALDI-TOF MS | |
Reich et al. | Species identification of bacteria and fungi from solid and liquid culture media by MALDI-TOF mass spectrometry | |
Kroumova et al. | Direct identification of bacteria in blood culture by matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry: a new methodological approach | |
US20170292142A1 (en) | Rapid Detection of Bacteria using Mass Spectrometric Analysis | |
CN111239235A (en) | Database establishment method and identification method of Bartonella strain MALDI-TOF MS | |
US20130309716A1 (en) | Methods For Inactiviation And/or Extraction of A Fungus Test Sample For Characterization And/or Identification Using Mass Spectrometry | |
Sacheli et al. | Evaluation of the new Id‐Fungi plates from Conidia for MALDI‐TOF MS identification of filamentous fungi and comparison with conventional methods as identification tool for dermatophytes from nails, hair and skin samples | |
Doellinger et al. | Evaluation of MALDI-ToF mass spectrometry for rapid detection of cereulide from Bacillus cereus cultures | |
CN104142375B (en) | A kind ofly utilize mould metabolic product to set up finger-print and utilize the method for fingerprint identification mold species | |
KR20180125402A (en) | Preparation of biological cells on mass spectrometric sample supports for desorbing ionization | |
CN112779343A (en) | Pathogenic microorganism drug sensitivity detection method | |
GB2480148A (en) | Mass Spectrometric Detection of Microbes | |
Ahmad et al. | High-resolution MALDI-TOF mass spectrometry of bacterial proteins using a Tris-EDTA buffer approach | |
CN112051321B (en) | Rapid antibiotic sensitivity testing method combining deuterium water culture and matrix-assisted laser desorption ionization time-of-flight mass spectrometry | |
CN111220686A (en) | Method for establishing mass spectrum database based on virus identification | |
Velichko et al. | Classification and identification tasks in microbiology: Mass spectrometric methods coming to the aid | |
Theel | Matrix-assisted laser desorption ionization-time of flight mass spectrometry for the identification of bacterial and fungal isolates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180727 |
|
CF01 | Termination of patent right due to non-payment of annual fee |